Clinical Trial Using AI Scores High Marks for Patients with Heart FailureAI Assistant Helps Recently Hospitalized Patients with Heart Failure Diagnosis
Christ Hospital Surgeons Perform Fourth-in-the-World Implant of the BiVACOR Total Artificial HeartCincinnati, Nov. 15, 2024 (GLOBE NEWSWIRE) -- CINCINNATI (November 15, 2024) – Surgeons at The Christ Hospital Health Network have successfully completed the fourth human implantation worldwide of the BiVACOR® Total Artificial Heart (TAH). This next-generation heart replacement device may be a revolutionary advance in cardiac care for patients with severe heart failure. The Christ Hospital is one of only four sites in the nation currently enrolling patients in an FDA-approved clinical trial.
